Neoadjuvant therapy may lead to successful surgical resection and improved survival in patients with borderline resectable pancreatic cancer.
about
Advances in chemotherapy for pancreatic cancerBorderline resectable pancreatic cancer: definitions and management.Therapeutic options for the management of pancreatic cancer.Resection of borderline resectable pancreatic cancer after neoadjuvant chemoradiation does not depend on improved radiographic appearance of tumor-vessel relationshipsUnresectable pancreatic adenocarcinoma with complete clinical response following chemoradiotherapy.Comparison of 1-, 2-, and 3-Dimensional Tumor Response Assessment After Neoadjuvant GTX-RT in Borderline-Resectable Pancreatic Cancer.Preoperative Biliary Drainage in Cases of Borderline Resectable Pancreatic Cancer Treated with Neoadjuvant Chemotherapy and Surgery.Innovations in macroscopic evaluation of pancreatic specimens and radiologic correlation.Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final resultsThe concept of 'borderline resectable' pancreatic cancer: limited foundations and limited future?Combined modality treatments in pancreatic cancer.Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design.Resectable, borderline resectable, and locally advanced pancreatic cancer: what does it matter?Pancreaticoduodenectomy with vascular resection for pancreatic head adenocarcinoma.The role of neoadjuvant therapy in pancreatic cancer: a review.Neoadjuvant chemoradiation therapy for borderline pancreatic adenocarcinoma: report of two cases.Outcomes of a Clinical Pathway for Borderline Resectable Pancreatic Cancer.Importance of resectability status in neoadjuvant treatment for pancreatic cancer.Neoadjuvant therapy for pancreatic cancer: an ongoing debate.Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients.Self-expanding metal stents (SEMS) for preoperative biliary decompression in patients with resectable and borderline-resectable pancreatic cancer: outcomes in 241 patients.Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer.Endoscopic Ultrasound and Related Technologies for the Diagnosis and Treatment of Pancreatic Disease - Research Gaps and Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.To drain or not to drain? That is the question.Pancreatectomy with Mesenteric and Portal Vein Resection for Borderline Resectable Pancreatic Cancer: Multicenter Study of 406 Patients.Optimal indication of neoadjuvant chemoradiotherapy for pancreatic cancer.Selective use of endoscopic ultrasound in the evaluation of carcinomas of the pancreatic head.Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie.Treatment of borderline resectable pancreatic cancer.Pathological and clinical impact of neoadjuvant chemoradiotherapy using full-dose gemcitabine and concurrent radiation for resectable pancreatic cancer.
P2860
Q28085711-F9B6E867-2BF3-4EF9-BEA1-437F6FC1357DQ34067852-4262AF9B-8509-43CD-A19E-80FBDB1F946AQ34093776-C1042AD5-F0F6-46E5-85E2-ED0D8FBA7883Q35155573-B13A7B3D-A4E2-4035-B3D8-5338043734C7Q35556905-173C6083-3374-4DA7-9A2A-5962BDDA2C46Q35768026-6592026D-36B4-4744-A8FF-9C2E5F3D0992Q36531542-B6DC74E5-16DA-45ED-8E60-52D88A836EB1Q36740066-28740FB3-9AF2-4CB3-8D5A-E2C08368EFA3Q36764997-83337712-BD8E-4EDF-9759-B701DA704452Q37677535-4BCFB2F2-978C-41FC-8E19-786361D5E3F8Q37996462-25A9F47C-ED7B-41C7-B646-302CB373B661Q38084124-96BB051B-BEC9-4303-8918-22CC363C330FQ38180310-EDC4F910-4071-498C-9C13-0C483FD6EAC2Q38212152-025B6785-156F-47A2-9F4F-3196BDA78C24Q38734981-809467EA-8C6A-49EE-AD3B-BDA256F0275FQ39302032-A878D1F5-E379-4430-A83E-BDFF253ECC6DQ40217786-BC00A858-4CE3-417A-AF46-A2D842DDE4C4Q41002447-1496D188-8E1E-4D8D-BA07-5112FA254666Q41826893-69EFAE6F-EE37-45C2-9D64-352B86AE82E5Q42374126-02B70777-D40B-45AD-BF3B-EF2C93C33DD1Q44238585-0D574A9C-24BC-4F9F-963C-95CD82AAD533Q44650366-BE5DA6C8-35A4-496E-8140-CCBBF7206432Q44815018-7A11968E-FAF9-4D7D-AD6A-5132F2D11B3CQ45889391-31FBF3FF-E02D-4FDE-8274-5E13E2D2CEFAQ48234367-2B3D6ABB-7E0D-4714-B3DC-0D487EC0E5A7Q50558607-5E1F7072-F599-41E5-99ED-CCEBED5A77BDQ50598630-8ECDAE3B-BDD4-4A44-A526-14945F2FE48BQ51009769-D8A9FA40-DE6A-466A-A491-14D0B7AB2898Q51196995-71A1D54B-C438-42A1-8EBD-992C97CAFCC1Q53153505-49DD77CC-148F-4244-8669-9AB8B0F249E3
P2860
Neoadjuvant therapy may lead to successful surgical resection and improved survival in patients with borderline resectable pancreatic cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Neoadjuvant therapy may lead t ...... resectable pancreatic cancer.
@ast
Neoadjuvant therapy may lead t ...... resectable pancreatic cancer.
@en
type
label
Neoadjuvant therapy may lead t ...... resectable pancreatic cancer.
@ast
Neoadjuvant therapy may lead t ...... resectable pancreatic cancer.
@en
prefLabel
Neoadjuvant therapy may lead t ...... resectable pancreatic cancer.
@ast
Neoadjuvant therapy may lead t ...... resectable pancreatic cancer.
@en
P2093
P2860
P1476
Neoadjuvant therapy may lead t ...... resectable pancreatic cancer.
@en
P2093
Andrew M Lowy
David L Grisell
Jeffrey J Sussman
Nathan Schmulewitz
Rebecca J McClaine
Syed A Ahmad
P2860
P356
10.1111/J.1477-2574.2009.00136.X
P577
2010-02-01T00:00:00Z